Two China Companies to Bid in $765 Million Auction for I-Med Radiology of Australia

Two China healthcare companies -- Tonghua Golden-Horse Pharma and Golden Meditech Holdings -- will submit bids in the second round of an auction to acquire I-MED Radiology, an Australian diagnostics service company. The bidding is expected to top $765 million. With nearly 200 clinics across Australia, I-MED is the nation’s largest diagnostic imaging services provider with 18% of the market. In 2016, I-MED reported $467 million in sales and $77 million in EBITDA. More details....

Stock Symbols: (SHZ: 000766) (HK: 0801)

Share this with colleagues:

Original Article: Two China Companies to Bid in $765 Million Auction for I-Med Radiology of Australia

More From BioPortfolio on "Two China Companies to Bid in $765 Million Auction for I-Med Radiology of Australia"

• Related Companies
• Related Events
• Related Clinical Trials
• Related PubMed Entries
• Related Medications